Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Schabel

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
The Journal of Infectious Diseases|March 19, 2010
The use of sulfadiazine and penicillin for treatment of experimental anthraxF M SCHABEL, H R REAMES, R D HOUSEWRIGHT
Cancer Treatment Reports|July 1, 1981
Synergistic antileukemic activity of combinations of two nitrosoureasG P Wheeler, F M Schabel, M W Trader
Biochemical Pharmacology|November 15, 1977
Biologic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine, a metabolically stable analog of 9-beta-D-arabinofuranosyladenineR W Brockman, F M Schabel, J A Montgomery
Klinika Oczna|January 1, 1971
The "sensitivity" of resting and dividing cellsR F Pittillo, F M Schabel, H E Skipper
Seminars in Hematology|July 1, 1978
Experimental therapeutics and kinetics: selection and overgrowth of specifically and permanently drug-resistant tumor cellsH E Skipper, F M Schabel, H H Lloyd
Cancer Chemotherapy Reports|October 1, 1970
Altered sensitivity of a hamster plasmacytoma to cytosine arabinoside (NSC-63878)D P Griswold, L Simpson-Herren, F M Schabel
Cancer Treatment Reports|January 1, 1981
Clonogenicity and growth of experimental tumors in relation to developing resistance and therapeutic failureD P Griswold, T H Corbett, F M Schabel
Cancer Research|September 1, 1970
Inhibition of ribonucleotide reductase, DNA synthesis, and L1210 leukemia by guanazoleR W Brockman, S Shaddix, W R Laster, et al.
Cancer Treatment Reports|September 1, 1978
Chronochemotherapy of L1210 leukemic mice with cytosine arabinoside or cyclophosphamideW C Rose, M W Trader, W R Laster, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1981
Absence of delayed lethality in mice treated with aclacinomycin AT H Corbett, D P Griswold, B J Roberts, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
The Journal of Infectious Diseases|March 19, 2010
The use of sulfadiazine and penicillin for treatment of experimental anthraxF M SCHABEL, H R REAMES, R D HOUSEWRIGHT
Cancer Treatment Reports|July 1, 1981
Synergistic antileukemic activity of combinations of two nitrosoureasG P Wheeler, F M Schabel, M W Trader
Biochemical Pharmacology|November 15, 1977
Biologic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine, a metabolically stable analog of 9-beta-D-arabinofuranosyladenineR W Brockman, F M Schabel, J A Montgomery
Klinika Oczna|January 1, 1971
The "sensitivity" of resting and dividing cellsR F Pittillo, F M Schabel, H E Skipper
Seminars in Hematology|July 1, 1978
Experimental therapeutics and kinetics: selection and overgrowth of specifically and permanently drug-resistant tumor cellsH E Skipper, F M Schabel, H H Lloyd
Cancer Chemotherapy Reports|October 1, 1970
Altered sensitivity of a hamster plasmacytoma to cytosine arabinoside (NSC-63878)D P Griswold, L Simpson-Herren, F M Schabel
Cancer Treatment Reports|January 1, 1981
Clonogenicity and growth of experimental tumors in relation to developing resistance and therapeutic failureD P Griswold, T H Corbett, F M Schabel
Cancer Research|September 1, 1970
Inhibition of ribonucleotide reductase, DNA synthesis, and L1210 leukemia by guanazoleR W Brockman, S Shaddix, W R Laster, et al.
Cancer Treatment Reports|September 1, 1978
Chronochemotherapy of L1210 leukemic mice with cytosine arabinoside or cyclophosphamideW C Rose, M W Trader, W R Laster, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1981
Absence of delayed lethality in mice treated with aclacinomycin AT H Corbett, D P Griswold, B J Roberts, et al.
Pageof 8